CERS Stock Analysis: Buy, Sell, or Hold?
CERS - Cerus Corp
$2.36
0.03 (1.29%)
▲
5d:
-4.07%
30d:
+14.56%
90d:
+68.57%
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 19, 2026
16d
Get Alerted When CERS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CERS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: CERS shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CERS is currently trading at $2.36, which is considered fair relative to its 30-day fair value range of $2.03 to $2.53.
Technical Outlook: Technically, CERS is in a strong uptrend. Immediate support is located at $2.25, while resistance sits at $2.74.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.67 (+100.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CERS is in a strong uptrend. Immediate support is located at $2.25, while resistance sits at $2.74.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.67 (+100.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$2.03 -
$2.53
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 100.3% below Wall St target ($4.67)
Fair Price Analysis
30-Day Fair Range
$2.03 -
$2.53
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$2.25
Resistance Level
$2.74
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-93.20
Wall Street Target
$4.67
(+100.3%)
Revenue Growth (YoY)
14.5%
Profit Margin
-8.0%
Last updated: February 02, 2026 10:37 AM ET
Data refreshes hourly during market hours. Next update: 11:37 AM
Data refreshes hourly during market hours. Next update: 11:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CERS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$134 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$370 | 54 HOLD |
